SEC Tracker
Get the app

Veradermics MANE

Veradermics reports positive Q3 2026 results

Veradermics (MANE) filed an 8-K with the SEC on Nov 10, 2026, 8:54 am ET. Source: the filing on SEC EDGAR.

Item 2.02 Reports results

Form
8-K
Filed
Importance
Major
  1. Cash and equivalents of $798.4 million as of September 30, 2026
  2. Positive topline results from Phase 3 Study '304' in male pattern hair loss
  3. Positive 12-month data from Phase 2/3 Study '302' showing robust hair growth
  4. Topline data from Phase 2/3 Study '306' expected in 1H27

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Veradermics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.